IL18 and neoplasm: As demonstrated by Xingjun Guo et al., IL-18 exemplifies this duality in PC: systemic elevation correlates with anti-tumor immunity and prolonged patient survival, whereas high intratumoral levels activate NF-κB to promote invasion, metastasis, and reduced survival (Figure 4).